GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Wednesday reported a loss of $35.3 million in its third quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 48 cents.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The biopharmaceutical company posted revenue of $13.2 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $13.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News